PDX Model Market: Driving Precision Oncology and Next-Generation Drug Discovery
The global PDX model market is projected to grow from USD 0.37 billion in 2025 to USD 0.66 billion by 2030, registering an impressive CAGR of 12.5%. The major factors driving the growth in the PDX model market include the rising demand for clinically relevant preclinical models that closely replicate human tumor biology and therapeutic response. Additionally, growth in the PDX model market is being...
PDX Model Market: Driving Precision Oncology and Next-Generation Drug Discovery
The landscape of cancer research and drug development is undergoing a profound transformation, with a growing emphasis on precision medicine and clinically relevant preclinical models. Among the most impactful innovations in this space are Patient-Derived Xenograft (PDX) models, which are redefining how researchers study tumor biology and evaluate therapeutic responses.
The global PDX model market...